| scholarly article | Q13442814 |
| P50 | author | Simona Giubilato | Q43302934 |
| Daniela Pedicino | Q43302950 | ||
| P2093 | author name string | Filippo Crea | |
| Francesco Trotta | |||
| Giovanna Liuzzo | |||
| Mara Campioni | |||
| Luigi Marzio Biasucci | |||
| Simona Giubilato | |||
| Anna Severino | |||
| Aureliano Ruggio | |||
| Daniela Pedicino | |||
| Giulia Angelini | |||
| Antonio Iaconelli | |||
| Ada Francesca Giglio | |||
| Vincenzo Pazzano | |||
| Davide Flego | |||
| Chiara Zara | |||
| Claudia Lucci | |||
| P2860 | cites work | Pathogenesis of acute coronary syndromes | Q27025887 |
| The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors | Q27860900 | ||
| Raised interleukin-10 is an indicator of poor outcome and enhanced systemic inflammation in patients with acute coronary syndrome | Q28219323 | ||
| Endotoxin, TLR4 signaling and vascular inflammation: potential therapeutic targets in cardiovascular disease | Q28273656 | ||
| Thymocyte development in early growth response gene 1-deficient mice | Q28508522 | ||
| A newly identified microRNA, mmu-miR-7578, functions as a negative regulator on inflammatory cytokines tumor necrosis factor-α and interleukin-6 via targeting Egr1 in vivo | Q28594135 | ||
| FOXP3+ regulatory T cells in the human immune system | Q29307487 | ||
| Inflammation, atherosclerosis, and coronary artery disease | Q29547232 | ||
| Statins reduce endothelial cell apoptosis via inhibition of TRAIL expression on activated CD4 T cells in acute coronary syndrome | Q34036983 | ||
| Early growth response transcription factors and the modulation of immune response: implications towards autoimmunity | Q34090036 | ||
| Early growth response-1 in cardiovascular pathobiology | Q34491148 | ||
| Genetically elevated C-reactive protein and ischemic vascular disease | Q34868720 | ||
| Posttranscriptional regulation of interleukin-10 expression by hsa-miR-106a | Q34967479 | ||
| Regulation of life and death by the zinc finger transcription factor Egr-1. | Q34972803 | ||
| Inflammation, endoplasmic reticulum stress, autophagy, and the monocyte chemoattractant protein-1/CCR2 pathway | Q35691449 | ||
| TRAIL-expressing T cells induce apoptosis of vascular smooth muscle cells in the atherosclerotic plaque | Q36227892 | ||
| Isoprenoids determine Th1/Th2 fate in pathogenic T cells, providing a mechanism of modulation of autoimmunity by atorvastatin | Q36228304 | ||
| Cellular actors, Toll-like receptors, and local cytokine profile in acute coronary syndromes | Q84171654 | ||
| Pharmacokinetic and pharmacodynamic alterations of 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitors: drug-drug interactions and interindividual differences in transporter and metabolic enzyme functions | Q36484039 | ||
| Local expression of Toll-like receptor 4 at the site of ruptured plaques in patients with acute myocardial infarction | Q36907993 | ||
| Pitavastatin suppresses mitogen activated protein kinase-mediated Erg-1 induction in human vascular smooth muscle cells | Q37165112 | ||
| Human regulatory T cells: role in autoimmune disease and therapeutic opportunities | Q37211296 | ||
| Transcriptional regulation of lymphocyte development | Q37262566 | ||
| CD4+ CD28 null T cells in coronary artery disease: when helpers become killers | Q37279626 | ||
| Heat-shock protein 60-reactive CD4+CD28null T cells in patients with acute coronary syndromes. | Q37867641 | ||
| T-bet expression is regulated by EGR1-mediated signaling in activated T cells | Q39869351 | ||
| Unusual CD4+CD28null T lymphocytes and recurrence of acute coronary events | Q40166868 | ||
| Early growth response-1 promotes atherogenesis: mice deficient in early growth response-1 and apolipoprotein E display decreased atherosclerosis and vascular inflammation | Q40608307 | ||
| Monoclonal T-cell proliferation and plaque instability in acute coronary syndromes | Q42628689 | ||
| Effects of simvastatin within two weeks on anti-inflammatory cytokine interleukin 10 in patients with unstable angina | Q42696068 | ||
| Novel anti-inflammatory effect of statins: reduction of CD4+CD28null T lymphocyte frequency in patients with unstable angina. | Q42833030 | ||
| Simvastatin induces Foxp3+ T regulatory cells by modulation of transforming growth factor-beta signal transduction | Q43090511 | ||
| The HMG-CoA reductase inhibitor, atorvastatin, promotes a Th2 bias and reverses paralysis in central nervous system autoimmune disease | Q43934617 | ||
| Interleukin 12 induces T-cell recruitment into the atherosclerotic plaque | Q44043461 | ||
| Simvastatin inhibits expression of tissue factor in advanced atherosclerotic lesions of apolipoprotein E deficient mice independently of lipid lowering: potential role of simvastatin-mediated inhibition of Egr-1 expression and activation | Q44485529 | ||
| 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors decrease Fas ligand expression and cytotoxicity in activated human T lymphocytes. | Q44571617 | ||
| High-dose atorvastatin enhances the decline in inflammatory markers in patients with acute coronary syndromes in the MIRACL study | Q44585429 | ||
| C-reactive protein levels and outcomes after statin therapy | Q45213511 | ||
| Statin therapy, LDL cholesterol, C-reactive protein, and coronary artery disease | Q45213515 | ||
| Rosuvastatin induces apoptosis in CD4+CD28null T cells in patients with acute coronary syndromes | Q45569404 | ||
| Statins induce regulatory T cell recruitment via a CCL1 dependent pathway. | Q46421497 | ||
| Expansion of circulating Toll-like receptor 4-positive monocytes in patients with acute coronary syndrome | Q46481417 | ||
| Enhanced T-helper-1 lymphocyte activation patterns in acute coronary syndromes | Q46553111 | ||
| Simvastatin inhibits IL-17 secretion by targeting multiple IL-17-regulatory cytokines and by inhibiting the expression of IL-17 transcription factor RORC in CD4+ lymphocytes. | Q46614190 | ||
| Changes of CD4+CD25+ regulatory T cells in patients with acute coronary syndrome and the effects of atorvastatin | Q46865229 | ||
| Simvastatin suppresses endotoxin-induced upregulation of toll-like receptors 4 and 2 in vivo. | Q46916581 | ||
| Increased PTPN22 expression and defective CREB activation impair regulatory T-cell differentiation in non-ST-segment elevation acute coronary syndromes. | Q54281605 | ||
| Altered status of CD4(+)CD25(+) regulatory T cells in patients with acute coronary syndromes | Q56901831 | ||
| Natural regulatory T cells control the development of atherosclerosis in mice | Q58149268 | ||
| Identification of unique adaptive immune system signature in acute coronary syndromes | Q58230139 | ||
| Expansion of CD4+CD28null T-lymphocytes in diabetic patients: exploring new pathogenetic mechanisms of increased cardiovascular risk in diabetes mellitus | Q58230169 | ||
| Perturbation of the T-Cell Repertoire in Patients With Unstable Angina | Q58230319 | ||
| Rapid immunomodulation by rosuvastatin in patients with acute coronary syndrome | Q79165981 | ||
| Lymphocyte responses in acute coronary syndromes: lack of regulation spawns deviant behaviour | Q79188054 | ||
| Clinical relevance of C-reactive protein during follow-up of patients with acute coronary syndromes in the Aggrastat-to-Zocor Trial | Q79922447 | ||
| Interleukin-18/interleukin-10 ratio is an independent predictor of recurrent coronary events during a 1-year follow-up in patients with acute coronary syndrome | Q79961588 | ||
| High-dose statins in acute coronary syndromes: not just lipid levels | Q80508763 | ||
| The effect of HMG-CoA reductase inhibitors on naturally occurring CD4+CD25+ T cells | Q81161461 | ||
| Clinical implications of inflammation for cardiovascular primary prevention | Q83038603 | ||
| Effect of CC chemokine receptor 2 CCR2 blockade on serum C-reactive protein in individuals at atherosclerotic risk and with a single nucleotide polymorphism of the monocyte chemoattractant protein-1 promoter region | Q83236917 | ||
| Chemokine CXCL10 promotes atherogenesis by modulating the local balance of effector and regulatory T cells | Q83305041 | ||
| P433 | issue | 11 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 17529-17550 | |
| P577 | publication date | 2017-03-01 | |
| P1433 | published in | Oncotarget | Q1573155 |
| P1476 | title | Atorvastatin inhibits the immediate-early response gene EGR1 and improves the functional profile of CD4+T-lymphocytes in acute coronary syndromes | |
| P478 | volume | 8 |
Search more.